目次
第1章 グローバル抗菌感受性検査（AST）市場 エグゼクティブサマリー
1.1. グローバル抗菌感受性検査市場規模および予測（2022年～2032年）
1.2. 地域別概要
1.3. 分野別概要
1.3.1. 製品別
1.3.2. 処置別
1.3.3. 用途別
1.3.4. エンドユース別
1.4. 主要動向
1.5. 不況の影響
1.6. アナリストの推奨事項および結論
第2章 世界の抗菌剤感受性試験市場の定義および調査の前提条件
2.1. 調査目的
2.2. 市場の定義
2.3. 調査の前提条件
2.3.1. 対象および除外
2.3.2. 制限
2.3.3. 供給サイド分析
2.3.3.1. 利用可能性
2.3.3.2. インフラ
2.3.3.3. 規制環境
2.3.3.4. 市場競争
2.3.3.5. 経済的実現可能性（消費者視点
2.3.4. 需要サイド分析
2.3.4.1. 規制枠組み
2.3.4.2. 技術的進歩
2.3.4.3. 環境への配慮
2.3.4.4. 消費者意識と受容
2.4. 推定方法
2.5. 調査対象年
2.6. 通貨換算レート
第3章 世界の抗菌剤感受性試験市場のダイナミクス
3.1. 市場推進要因
3.1.1. 抗菌剤耐性の増加
3.1.2. 個別化医療の進歩
3.1.3. AMR対策を目的とした政府による好意的な政策
3.2. 市場の課題
3.2.1. 先進的なASTシステムのコストの高さ
3.2.2. AST技術における標準化の限界
3.3. 市場の機会
3.3.1. 迅速なAST技術の拡大
3.3.2. 特にアジア太平洋地域における医療インフラへの投資の増加
第4章 世界の抗菌薬感受性検査市場の産業分析
4.1. ポーターのファイブフォースモデル
4.1.1. 供給業者の交渉力
4.1.2. 購入業者の交渉力
4.1.3. 新規参入の脅威
4.1.4. 代替品の脅威
4.1.5. 競合他社との競争
4.2. PESTEL分析
4.2.1. 政治
4.2.2. 経済
4.2.3. 社会
4.2.4. 技術
4.2.5. 環境
4.2.6. 法律
4.3. 主な投資機会
4.4. 破壊的トレンド
4.5. 業界専門家による見解
第5章 製品別 抗菌薬感受性検査（AST）の世界市場規模・予測（2022年～2032年）
5.1. セグメントダッシュボード
5.2. 手動検査
5.2.1. MICストリップ
5.2.2. 感受性検査ディスク
5.2.3. 感受性プレート
5.3. 自動化機器
5.4. 消耗品および培地
第6章 グローバル抗菌薬感受性試験市場規模および予測（2022年～2032年） 処置別
6.1. セグメントダッシュボード
6.2. ディスク拡散
6.3. 自動化AST
6.4. Etest法
6.5. その他
第7章 グローバル抗菌薬感受性試験市場規模および予測（2022年～2032年） 用途別
7.1. セグメントダッシュボード
7.2. 医薬品開発
7.3. 感受性試験
7.4. その他
第8章 世界の抗菌薬感受性検査市場規模および予測（2022年～2032年）エンドユース別
8.1. セグメントダッシュボード
8.2. 病院
8.3. 診断ラボ
8.4. バイオテクノロジーおよび製薬会社
8.5. その他
第9章 世界の薬剤感受性検査市場規模および地域別予測（2022年～2032年）
9.1. 北米
9.1.1. 米国
9.1.2. カナダ
9.2. ヨーロッパ
9.2.1. 英国
9.2.2. ドイツ
9.2.3. フランス
9.2.4. スペイン
9.2.5. イタリア
9.2.6. スウェーデン
9.2.7. ノルウェー
9.2.8. デンマーク
9.3. アジア太平洋地域
9.3.1. 中国
9.3.2. インド
9.3.3. 日本
9.3.4. 韓国
9.3.5. オーストラリア
9.3.6. タイ
9.4. ラテンアメリカ
9.4.1. ブラジル
9.4.2. メキシコ
9.4.3. アルゼンチン
9.5. 中東およびアフリカ
9.5.1. サウジアラビア
9.5.2. 南アフリカ
9.5.3. アラブ首長国連邦
9.5.4. クウェート
第10章 競合情報
10.1. 主要企業のSWOT分析
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. BD (Becton, Dickinson, and Company)
10.1.3. bioMérieux SA
10.2. トップ市場戦略
10.3. 企業プロフィール
Thermo Fisher Scientific Inc.
BD (Becton, Dickinson, and Company)
bioMérieux SA
Danaher Corporation
Bio-Rad Laboratories Inc.
Merck & Co., Inc.
Siemens Healthineers
Creative Diagnostics
F. Hoffmann-La Roche Ltd
Hi-Media Laboratories Pvt. Ltd.
ELITechGroup
COPAN Diagnostics Inc.
Agilent Technologies Inc.
Beckman Coulter Inc.
NanoSynex Ltd.
第11章 調査プロセス
11.1. 調査プロセス
11.1.1. データマイニング
11.1.2. 分析
11.1.3. 市場推定
11.1.4. 検証
11.2. 調査属性
AST plays a pivotal role in combating antimicrobial resistance (AMR), a growing global health crisis caused by the overuse and misuse of antibiotics. This testing method enables healthcare providers to identify the most effective antimicrobial therapy, minimizing treatment failures and the spread of resistant pathogens.
The market's expansion is driven by the rising incidence of drug-resistant infections and an increasing focus on personalized medicine, where tailored treatments demand precise diagnostic solutions like AST. Government initiatives, such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) and the Global Antibiotic Resistance and Usage Surveillance System (GLASS), are further bolstering the adoption of AST technologies. These efforts reflect the global commitment to reducing AMR through improved diagnostics and therapeutic strategies.
Technological advancements, particularly in automated AST systems, are reshaping the industry landscape. Automated systems offer higher accuracy, reduced errors, and faster turnaround times compared to manual methods. Recent innovations, such as rapid AST solutions capable of delivering results within hours, are accelerating their adoption in clinical and research settings. Companies like NanoSynex Ltd. and COPAN Diagnostics are at the forefront, introducing next-generation AST tools to the market.
Regional dynamics reveal North America as the dominant market, supported by advanced healthcare infrastructure, a high prevalence of multidrug-resistant infections, and substantial investments in R&D. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth, driven by increasing healthcare expenditures, growing awareness of AMR, and initiatives to modernize healthcare systems. Europe also plays a significant role, benefiting from supportive policies and a focus on technological innovation.
________________________________________
Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• BD (Becton, Dickinson, and Company)
• bioMérieux SA
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Siemens Healthineers
• Creative Diagnostics
• F. Hoffmann-La Roche Ltd
• Hi-Media Laboratories Pvt. Ltd.
• ELITechGroup
• COPAN Diagnostics Inc.
• Agilent Technologies Inc.
• Beckman Coulter Inc.
• NanoSynex Ltd.
________________________________________
The detailed segments and sub-segments of the market are explained below:
By Product:
• Manual Tests
o MIC Strips
o Susceptibility Testing Disks
o Susceptibility Plates
• Automated Instruments
• Consumables & Media
By Technique:
• Disk Diffusion
• Automated AST
• Etest Method
• Dilution
• Others
By Application:
• Drug Development
• Susceptibility Testing
• Others
By End-Use:
• Hospitals
• Diagnostic Laboratories
• Biotechnology & Pharmaceutical Companies
• Others
By Region:
• North America:
o U.S.
o Canada
• Europe:
o U.K.
o Germany
o France
o Spain
o Italy
o Sweden
o Norway
o Denmark
• Asia-Pacific:
o China
o India
o Japan
o South Korea
o Australia
o Thailand
• Latin America:
o Brazil
o Mexico
o Argentina
• Middle East & Africa:
o Saudi Arabia
o South Africa
o UAE
o Kuwait
________________________________________
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.
Table of Content
Chapter 1. Global Antimicrobial Susceptibility Testing Market Executive Summary
1.1. Global Antimicrobial Susceptibility Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technique
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Antimicrobial Susceptibility Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antimicrobial Susceptibility Testing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of antimicrobial resistance
3.1.2. Advancements in personalized medicine
3.1.3. Favorable government policies to combat AMR
3.2. Market Challenges
3.2.1. High costs of advanced AST systems
3.2.2. Limited standardization in AST techniques
3.3. Market Opportunities
3.3.1. Expansion of rapid AST technologies
3.3.2. Rising investments in healthcare infrastructure, especially in APAC
Chapter 4. Global Antimicrobial Susceptibility Testing Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Disruptive Trends
4.5. Industry Expert Perspectives
Chapter 5. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Manual Tests
5.2.1. MIC Strips
5.2.2. Susceptibility Testing Disks
5.2.3. Susceptibility Plates
5.3. Automated Instruments
5.4. Consumables & Media
Chapter 6. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Technique (2022-2032)
6.1. Segment Dashboard
6.2. Disk Diffusion
6.3. Automated AST
6.4. Etest Method
6.5. Others
Chapter 7. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Application (2022-2032)
7.1. Segment Dashboard
7.2. Drug Development
7.3. Susceptibility Testing
7.4. Others
Chapter 8. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by End-Use (2022-2032)
8.1. Segment Dashboard
8.2. Hospitals
8.3. Diagnostic Laboratories
8.4. Biotechnology & Pharmaceutical Companies
8.5. Others
Chapter 9. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Region (2022-2032)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Sweden
9.2.7. Norway
9.2.8. Denmark
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. BD (Becton, Dickinson, and Company)
10.1.3. bioMérieux SA
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific Inc.
10.3.2. BD (Becton, Dickinson, and Company)
10.3.3. Danaher Corporation
10.3.4. Bio-Rad Laboratories Inc.
10.3.5. Merck & Co., Inc.
10.3.6. Siemens Healthineers
10.3.7. Creative Diagnostics
10.3.8. COPAN Diagnostics Inc.
10.3.9. ELITechGroup
10.3.10. Hi-Media Laboratories Pvt. Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.2. Research Attributes
❖ 掲載企業 ❖
Thermo Fisher Scientific Inc.、BD (Becton, Dickinson, and Company)、bioMérieux SA、Danaher Corporation、Bio-Rad Laboratories Inc.、Merck & Co., Inc.、Siemens Healthineers、Creative Diagnostics、F. Hoffmann-La Roche Ltd、Hi-Media Laboratories Pvt. Ltd.、ELITechGroup、COPAN Diagnostics Inc.、Agilent Technologies Inc.、Beckman Coulter Inc.、NanoSynex Ltd.など
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
